About

About LAT RESEARCH SRL LAT Research is a privately held Contract Research Organization (CRO), founded in 2010 and an active member of the Argentine Chamber of Clinical Research Organizations (CAOIC). We specialize in providing regulatory-compliant, high-quality clinical research services across Latin America. We partner with global sponsors to facilitate clinical development in alignment with international regulatory standards, including those of the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and ANMAT (Argentina’s National Administration of Drugs, Food and Medical Technology). ________________________________________ Clinical Trial Experience Since its establishment, our clinical operations team has supported more than 70 clinical trials across multiple phases and therapeutic areas. Our proven track record includes • Orphan and rare diseases • Translational medicine • Neglected and infectious diseases • Studies involving vulnerable or underserved populations Our operational strategies are aligned with ICH-GCP guidelines and tailored to meet both regional and global regulatory expectations. Regional Capabilities LAT Research is led by a team of senior physicians and industry experts with over 25 years of experience in clinical development and regulatory affairs. We maintain dedicated teams across Latin America, allowing for • Efficient site selection and patient recruitment • Deep understanding of local regulatory frameworks (FDA, EMA, ANMAT, INVIMA, COFEPRIS, among others) • Seamless coordination of multicenter studies Comprehensive Services for Sponsors We offer full-service CRO capabilities from early-phase trials through to registration and post-marketing studies, including: • Clinical development • Regulatory strategy and submissions • Site management and monitoring • Data management and biostatistics • Pharmacovigilance • Quality assurance and audit support Why Global Sponsors Choose LAT Research • Expertise in regulatory navigation across Latin American countries • Proven performance in complex, multicenter studies • Strong investigator networks and KOL relationships • Flexibility and client-centered project delivery • Commitment to quality, ethics, and operational excellence